Biotech startup Helex raises $3.5 million in round led by pi Ventures

Share via:



Hyderabad- and US-based biotech startup Helex has raised $3.5 million in a seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and other global investors.

The startup is developing targeted genomic medicines for kidney diseases using its proprietary lipid nanoparticle (LNP) delivery and artificial intelligence (AI)-driven drug design platforms.

Incubated at ASPIRE–BioNEST, University of Hyderabad, Helex aims to make gene therapies more precise, accessible, and affordable, its founders told ET.

The funding will accelerate…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Biotech startup Helex raises $3.5 million in round led by pi Ventures



Hyderabad- and US-based biotech startup Helex has raised $3.5 million in a seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and other global investors.

The startup is developing targeted genomic medicines for kidney diseases using its proprietary lipid nanoparticle (LNP) delivery and artificial intelligence (AI)-driven drug design platforms.

Incubated at ASPIRE–BioNEST, University of Hyderabad, Helex aims to make gene therapies more precise, accessible, and affordable, its founders told ET.

The funding will accelerate…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

3 Ways Enterprises Can Scale AI Gains in 2026

Most organizations are ending 2025 with tangible AI...

What is Claude for Healthcare? Anthropic launches new AI...

Anthropic has launched a new service called Claude...

WhatsApp beta for iOS 26.1.10.72: what’s new?

WhatsApp has released a new iOS update through...

Popular

iptv iptv iptv